W.L. Gore

1 month ago | bioprocessonline.com | David Seifert |Joe Cintavey |W.L. Gore |Tyler Menichiello

BoB@JPM: Tom Chalberg, Ph.D., GenascenceJoin Business of Biotech’s Matt Pillar and Ben Comer as they dive into the future of gene therapy with Dr. Tom Chalberg, CEO of Genascence. The discussion explores the shift from rare disease treatments to common conditions like osteoarthritis, the challenges of delivery and regulation, and Genascence’s partnership strategy.

Apr 3, 2024 | bioprocessonline.com | Diane McCarthy |Li Jing |William Barrett |W.L. Gore

Welcome to the redesigned Bioprocess Online newsletter! In addition to having a new look, the newsletter will now be delivered daily, and each issue will focus on a specific topic or topics. Visit your profile page to update your topic preferences and receive only the newsletter(s) of interest to you. FOCUS ON DOWNSTREAM MANUFACTURINGWhen characterizing PQAs, the multi-attribute method offers a one-stop shop for analysis. This article explores technical considerations for this emerging strategy.

Mar 18, 2024 | aviationweek.com | W.L. Gore

It’s called “power density,” and it defines the boundary between the present and our long-awaited electric aircraft future. The burden is on the aviation industry to innovate rapidly. In July 2023, the UN organization ICAO Environment issued its “Electric Innovations for Sustainable Aviation.”[1] The document proposes significant progress in long-term (post-2040) reduction of air pollution, noise, maintenance costs and factors affecting climate change.